| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $757.5M | +9.0% |
| Cost of Revenue | $344.1M | +6.4% |
| Gross Profit | $413.4M | +11.3% |
| R&D Expense | $121.6M | -7.9% |
| SG&A Expense | $114.4M | +5.2% |
| Operating Income | -$77.4M | +31.6% |
| Pre-tax Income | -$45.9M | +41.5% |
| Income Tax | $5.1M | +395.6% |
| Net Income | -$51.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $792.6M | +9.2% |
| Accounts Receivable | $65.4M | +9.6% |
| Current Assets | $898.1M | +8.1% |
| Total Assets | $1.00B | +7.5% |
| Current Liabilities | $357.9M | +9.3% |
| Total Liabilities | $364.3M | +9.4% |
| Stockholders' Equity | $635.7M | +6.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $108.7M | +14.0% |
| Investing Cash Flow | -$30.2M | -201.0% |
| Financing Cash Flow | -$13.5M | +75.4% |
| +35.9% |
| EPS (Basic) | -$0.31 | +39.2% |
| EPS (Diluted) | -$0.31 | +39.2% |